Results for “Accelerated Life Testing” — Page 20

DOE OSTI2024

Intraspecific variability in plant and soil chemical properties in a common garden plantation of the energy crop Populus

Optimizing crops for synergistic soil carbon (C) sequestration can enhance CO 2 removal in food and bioenergy production systems. Yet, in bioenergy systems, we lack an understanding of how intraspecies variation in plant traits correlates with variation in soil biogeochemistry. This knowledge gap is exacerbated by both the heterogeneity and difficulty of measuring belowground traits. Here, we provide initial observations of C and nutrients in soil and root and stem tissues from a common garden field site of diverse, natural variant, Populus trichocarpa genotypes—established for aboveground biomass-to-biofuels research. Our goal was to explore the value of such field sites for evaluating genotype-specific effects on soil C, which ultimately informs the potential for optimizing bioenergy systems for both aboveground productivity and belowground C storage. To do this, we investigated variation in chemical traits at the scale of individual trees and genotypes and we explored correlations among stem, root, and soil samples. We observed substantial variation in soil chemical properties at the scale of individual trees and specific genotypes. While correlations among elements were observed both within and among sample types (soil, stem, root), above-belowground correlations were generally poor. We did not observe genotype-specific patterns in soil C in the top 10 cm, but we did observe genotype associations with soil acid-base chemistry (soil pH and base cations) and bulk density. Finally, a specific phenotype of interest (high vs low lignin) was unrelated to soil biogeochemistry. Our pilot study supports the usefulness of decade-old, genetically-variable, Populus bioenergy field test plots for understanding plant genotype effects on soil properties. Finally, this study contributes to the advancement of sampling methods and baseline data for Populus systems in the Pacific Northwest, USA. Further species- and region-specific efforts will enhance C predictability across scales in bioenergy systems and, ultimately, accelerate the identification of genotypes that optimize yield and carbon storage.

54 ENVIRONMENTAL SCIENCES↗

DOE OSTI2022

Life after 30 years - a PV system in Colorado

The PV system consisted of 155 monocrystalline Si Arco M53 panels, installed in 1987. 80 were installed on a fixed tilt rack, and 75 on 5 separate dual-axis passive trackers. The system was decommissioned in 2017 due a campus re-design and building expansion at the Platte River Power Authority (PPRA) site. Prior to decommissioning a site visit established the following failure type observations: EVA browning (100%), cracked cells (60%), and cracked wires or grommets (9%, or more if replacements were made selectively on cracked parts). EVA browning is typical in modules of this vintage, whereas the occurrence of so many cracked cells is surprising and is likely weather-related. The fairly frequent occurrence of cracked wires and grommets serves as a reminder that accelerated testing of these components is important for goals of low-cost 50-year energy generation. In smaller numbers, thermal effects (7%), bent frames (1%), and cell corrosion (<1%) were observed. A sample of 20 modules was selected and brought to NREL for in-depth characterization. Because baseline measurements were not available using the nameplate rating, which can be inaccurate, revealed a mean module sample degradation of 0.7 %/year. Sporadic production data during the 30 years determined a system degradation rate closer to 1.2 %/year. Subsequently, four of these modules were re-mounted outdoors at NREL and are now approaching a total lifetime of 34 years.

durability↗

DOE OSTI2014

SU-E-T-152: Error Sensitivity and Superiority of a Protocol for 3D IMRT Quality Assurance

Purpose: To test if the parameters included in our 3D QA protocol with current tolerance levels are able to detect certain errors and show the superiority of 3D QA method over single ion chamber measurements and 2D gamma test by detecting most of the introduced errors. The 3D QA protocol parameters are: TPS and measured average dose difference, 3D gamma test with 3mmDTA/3% test parameters, and structure volume for which the TPS predicted and measured absolute dose difference is greater than 6%. Methods: Two prostate and two thoracic step-and-shoot IMRT patients were investigated. The following errors were introduced to each original treatment plan: energy switched from 6MV to 10MV, linac jaws retracted to 15cmx15cm, 1,2,3 central MLC leaf pairs retracted behind the jaws, single central MLC leaf put in or out of the treatment field, Monitor Units (MU) increased and decreased by 1 and 3%, collimator off by 5 and 15 degrees, detector shifted by 5mm to the left and right, gantry treatment angle off by 5 and 15 degrees. QA was performed on each plan using single ion chamber, 2D ion chamber array for 2D gamma analysis and using IBA's COMPASS system for 3D QA. Results: Out of the three tested QA methods single ion chamber performs the worst not detecting subtle errors. 3D QA proves to be the superior out of the three methods detecting all of introduced errors, except 10MV and 1% MU change, and MLC rotated (those errors were not detected by any QA methods tested). Conclusion: As the way radiation is delivered evolves, so must the QA. We believe a diverse set of 3D statistical parameters applied both to OAR and target plan structures provides the highest level of QA.

07 ISOTOPE AND RADIATION SOURCES↗

DOE OSTI2013

Advanced Models of LWR Pressure Vessel Embrittlement for Low Flux-High Fluence Conditions

Neutron embrittlement of reactor pressure vessels (RPVs) is an unresolved issue for light water reactor life extension, especially since transition temperature shifts (TTS) must be predicted for high 80-year fluence levels up to approximately 1,020 n/cm 2 , far beyond the current surveillance database. Unfortunately, TTS may accelerate at high fluence, and may be further amplified by the formation of late blooming phases that result in severe embrittlement even in low-copper (Cu) steels. Embrittlement by this mechanism is a potentially significant degradation phenomenon that is not predicted by current regulatory models. This project will focus on accurately predicting transition temperature shifts at high fluence using advanced physically based, empirically validated and calibrated models. A major challenge is to develop models that can adjust test reactor data to account for flux effects. Since transition temperature shifts depend on synergistic combinations of many variables, flux-effects cannot be treated in isolation. The best current models systematically and significantly under-predict transition temperature at high fluence, although predominantly for irradiations at much higher flux than actual RPV service. This project will integrate surveillance, test reactor and mechanism data with advanced models to address a number of outstanding RPV embrittlement issues. The effort will include developing new databases and preliminary models of flux effects for irradiation conditions ranging from very low (e.g., boiling water reactor) to high (e.g., accelerated test reactor). The team will also develop a database and physical models to help predict the conditions for the formation of Mn-Ni-Si late blooming phases and to guide future efforts to fully resolve this issue. Researchers will carry out other tasks on a best-effort basis, including prediction of transition temperature shift attenuation through the vessel wall, remediation of embrittlement by annealing, and fracture toughness master curve issues.

22 GENERAL STUDIES OF NUCLEAR REACTORS↗

DOE OSTI2025

Custom Equipment Development for Processing of Surplus Plutonium

The Strategic Laboratory Assessment (SLA), a collaborative team of SRNL and ORNL personnel, has been established to advance the objectives of the Surplus Plutonium Disposition (SPD) Project, by identifying and developing technologies to accelerate disposition, reduce life cycle costs, minimize worker radiation exposure, improve worker safety, and minimize Surplus Plutonium Disposition Program risks. [1] The SLA team has identified can cutting and plutonium (Pu) oxide size reduction as two glovebox processes where technology enhancements would be valuable. The DOESTD-3013 package currently in use for Pu downblending requires cutting two nested cans before the inner convenience can that holds the Pu oxide may be accessed for further processing. A rotary tubing-style cutter is used for opening the 3013 packages within the glovebox. Collet changeouts are required between cutting of the outer and inner cans. The SLA team is currently developing and testing an adjustable-clamp can cutter design that eliminates collet changeouts and allows cutting of the outer and inner can at the same time, resulting in significant reduction of radiological dose and process time, as well as improved ergonomics. To meet the Pu oxide particle size requirement, size reduction of Pu oxide agglomerations must be performed within the process gloveboxes. The SLA team has identified jaw crushing technology as an alternative to the currently employed rotary mill. Jaw crusher advantages include reduced dust within the glovebox, increased batch sizes, and easier integration with other glovebox processes due to the flow-through nature of jaw crushing. Commercially manufactured jaw crushers are either too large and/or too heavy for implementation in the SPD gloveboxes, so the SLA team is developing and testing a custom jaw crusher to meet the needs of the SPD Project.

Krementz, Daniel [Savannah River National Laborato↗

DOE OSTI2016

TH-AB-BRB-00: Research Opportunities with Digital Linear Accelerators

Current state-of-the art digital C-arm medical linear accelerators are capable of delivering radiation treatments with high level of automation, which affords coordinated motions of gantry, couch, and multileaf collimator (MLC) with dose rate modulations. The new machine capacity has shown the potential to bring substantially improved radiation dosimetry and/or delivery efficiency to many challenging diseases. Combining an integrated beam orientation optimization algorithm with automated machine navigation, markedly improved dose conformity has been achieved using 4ρ therapy. Trajectory modulated radiation therapy (TMAT) can be used to deliver highly conformal dose to partial breast or to carve complex dose distribution for therapy involving extended volumes such as total marrow and total lymph node treatment. Dynamic electron arc radiotherapy (DEAR) not only overcomes the deficiencies of conventional electron therapy in dose conformity and homogeneity but also achieves so without patient-specific shields. The combination of MLC and couch tracking provides improved motion management of thoracic and abdominal tumors. A substantial body of work has been done in these technological advances for clinical translation. The proposed symposium will provide a timely review of these exciting opportunities. Learning Objectives: Recognize the potential of using digitally controlled linacs for clinically significant improvements in delivered dose distributions for various treatment sites. Identify existing approaches to treatment planning, optimization and delivery for treatment techniques utilizing the advanced functions of digital linacs and venues for further development and improvement. Understand methods for testing and validating delivery system performance. Identify tools available on current delivery systems for implementation and control for such treatments. Obtain the update in clinical applications, trials and regulatory approval. K. Sheng, NIH U19AI067769, NIH R43CA183390, NIH R01CA188300, Varian Medical Systems V. Yu, Varian Medical Systems, AAPM Summer Undergraduate Fellowship, NSF graduate fellowship S. Nill, Elekta AB. Cancer Research UK under Programme C33589/A19727, NIHR Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2010

Coolant Compatibility Studies for Fusion and Fusion-Fission Hybrid Reactor Concepts: Corrosion of Oxide Dispersion Strengthened Iron-Chromium Steels and Tantalum in High Temperature Molten Fluoride Salts

Alloys such as 12YWT & 14YWT have exceptional high-temperature strength at temperatures greater than 550 C. This class of materials has also demonstrated relatively little radiation induced swelling at damage levels of at least 75 dpa in sodium-cooled fast reactors. However, corrosion of oxide dispersion strengthened (ODS) steels in high temperature molten fluoride salts may limit the life of advanced reactor systems, including some fusion and fusionfission hybrid systems that are now under consideration. This paper reports corrosion studies of ODS steel in molten fluoride salts at temperatures ranging from 600 to 900 C. Electrochemical impedance spectroscopy (EIS) was used to measure the temperature dependence of charge transfer kinetics in situ, while an environmental electron microscope (ESEM) equipped with energy dispersive spectroscopy (EDS) was used for postexposure examination of test samples. ODS steel experienced corrosion in the molten fluoride salts at 550 to 900 C, even in carefully controlled glove-box environments with very low levels of oxygen and moisture. The observed rate of attack was found to accelerate dramatically at temperatures above 800 C. Tantalum and tantalum-based alloys such as Ta-1W and Ta-10W have exceptional high temperature strength, far better than ODS steels. Unlike ODS steels, tantalum has been found to exhibit some immunity to corrosive attack by molten fluoride salts at temperatures as high as 900 C, though there is some indication that grain boundary attack may have occurred. Unfortunately, tantalum alloys are known to become brittle during irradiation and exposure to hydrogen, both of which are important in fusion applications.

36 MATERIALS SCIENCE↗

DOE OSTI2018

Effects of W on creep behaviors of novel Nb-bearing high nitrogen austenitic heat-resistant cast steels at 1000 °C

Highlights: • The synergistic CALPHAD and experimental approaches are adopted. • Creep behaviors of high nitrogen austenitic alloys are investigated at 1000 °C. • Creep properties are improved through the W solid solution strengthening. • W additions promote the formation of (Cr,Fe,W){sub 23}C{sub 6} instead of (Cr,Fe,W){sub 7}C{sub 3}. • (Cr, W)-rich precipitates severely degrade the creep properties. - Abstract: Recently, there is an urgent demand from automotive industries to develop new austenitic heat-resistant cast steels that withstand exhaust gas temperatures as high as 1000 °C. In this study, the effect of W additions on the creep behavior of a series of Nb-bearing high nitrogen austenitic heat-resistant cast steels was investigated at 1000 °C and 50 MPa. Microstructures before and after creep rupture tests were carefully characterized to illustrate the microstructural evolution during creep deformation. Microstructural analyses revealed that the W addition did not affect the formation of primary Nb(C,N), whereas significantly promoted the precipitation of primary (Cr, W)-rich phases, particularly those cellular structures along grain boundaries. The W solid solution strengthening and the secondary precipitation strengthening of submicron-scale (Cr, W)-rich phase improved the creep resistance of the alloys through increasing the hardness of γ-austenite and pinning the dislocations. However, the primary cellular (Cr, W)-rich structures significantly accelerated the nucleation and propagation of creep cracks along grain boundaries, thereby increasing the creep rate and decreasing the creep life.

36 MATERIALS SCIENCE↗

DOE OSTI2022

Experimental Characterization of Hygrothermal Aging: Competition Between Thermo-Oxidation and Hydrolysis Phenomena

Abstract In this work, we have presented a comparison between effects of accelerated thermo-oxidative, hydrolytic and hygrothermal aging on the mechanical and chemical properties of a polyurethane based (PUB) adhesive. The adhesive is a flexible adhesive which is extensively used in automobile industry as a glass sealant. During service life it gets exposed to the hygrothermal environment and the integrity of matrix interface is most vulnerable. This study focuses on weighing and comparing effects of different aging environments on material behavior; and it shows that hygrothermal aging environment results as a competition between two sub-aging phenomena i.e., thermo-oxidation and hydrolytic aging. Samples were exposed to 0%RH, 80%RH and submerged condition in distilled water. Uni-axial tensile tests, and cross-link density analysis by swelling test were carried out on as-received and aged samples. The aging process was conducted at three different temperatures (60°C, 80°C and 95°C) and for four different exposure durations of 1, 10, 30, and 90 days. This work confirms that the effect of hygrothermal aging is a result of competition between thermo-oxidation and hydrolytic aging environments. The total mechanical and environmental damage incurred by specimens is a collaborative effect of all exposure environments involved i.e., aging time, temperature, oxygen, water and humidity. The results are in agreement with the chemical test outcomes as well.

Shaafaey, Mamoon↗

DOE OSTI2019

Extreme Temperature Sample Environment for Materials Research Using Neutron Scattering

Extreme temperatures and non-equilibrium materials are both central to Department of Energy’s (DOE) mission of addressing grand challenges in emerging energy and advanced materials technologies. The goal of this project is to develop and perfect a system for studying materials in extreme and non-equilibrium conditions using neutron scattering. Neutron scattering has many advantages in the study of materials structure including the ability to use isotopic substitution to determine partial structure factors. When used at a pulsed neutron source, the potential for event-based detection can enable a stroboscopic technique to interrogate very short lived metastable states in supercooled liquids. The work performed in this Phase I project included: (i) literature reviews and discussions with beamline scientists to establish key requirements for the instrument, (ii) laboratory-based research at Materials Development, Inc. (MDI) to test design concepts, modify control software and model designs, (iii) feasibility experiments and measurements on a prototype sample at the Spallation Neutron Source, and (iv) analysis of the results and design of the proposed Phase II instrument. The results of the work show that the proposed approach is viable and provides a strong basis for the Phase II instrument design and Phase III commercialization. MDI participated in the DOE Commercialization Assistance Program with the Larta Institute (Larta) to accelerate commercial sales of the instruments. The market research identified a served available market of ~13M including sales to beamlines, university research laboratories, and industrial glass and materials businesses. Over the ca. 10 year product life cycle, MDI expects to sell instruments with a cumulative net present value profit of approximately 5M.

47 OTHER INSTRUMENTATION↗

DOE OSTI2016

TH-AB-BRB-01: Trajectory Modulated Arc Therapy: Application to Partial Breast Irradiation

Current state-of-the art digital C-arm medical linear accelerators are capable of delivering radiation treatments with high level of automation, which affords coordinated motions of gantry, couch, and multileaf collimator (MLC) with dose rate modulations. The new machine capacity has shown the potential to bring substantially improved radiation dosimetry and/or delivery efficiency to many challenging diseases. Combining an integrated beam orientation optimization algorithm with automated machine navigation, markedly improved dose conformity has been achieved using 4ρ therapy. Trajectory modulated radiation therapy (TMAT) can be used to deliver highly conformal dose to partial breast or to carve complex dose distribution for therapy involving extended volumes such as total marrow and total lymph node treatment. Dynamic electron arc radiotherapy (DEAR) not only overcomes the deficiencies of conventional electron therapy in dose conformity and homogeneity but also achieves so without patient-specific shields. The combination of MLC and couch tracking provides improved motion management of thoracic and abdominal tumors. A substantial body of work has been done in these technological advances for clinical translation. The proposed symposium will provide a timely review of these exciting opportunities. Learning Objectives: Recognize the potential of using digitally controlled linacs for clinically significant improvements in delivered dose distributions for various treatment sites. Identify existing approaches to treatment planning, optimization and delivery for treatment techniques utilizing the advanced functions of digital linacs and venues for further development and improvement. Understand methods for testing and validating delivery system performance. Identify tools available on current delivery systems for implementation and control for such treatments. Obtain the update in clinical applications, trials and regulatory approval. K. Sheng, NIH U19AI067769, NIH R43CA183390, NIH R01CA188300, Varian Medical Systems V. Yu, Varian Medical Systems, AAPM Summer Undergraduate Fellowship, NSF graduate fellowship S. Nill, Elekta AB. Cancer Research UK under Programme C33589/A19727, NIHR Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2016

TH-AB-BRB-02: ET-Reloaded

Current state-of-the art digital C-arm medical linear accelerators are capable of delivering radiation treatments with high level of automation, which affords coordinated motions of gantry, couch, and multileaf collimator (MLC) with dose rate modulations. The new machine capacity has shown the potential to bring substantially improved radiation dosimetry and/or delivery efficiency to many challenging diseases. Combining an integrated beam orientation optimization algorithm with automated machine navigation, markedly improved dose conformity has been achieved using 4ρ therapy. Trajectory modulated radiation therapy (TMAT) can be used to deliver highly conformal dose to partial breast or to carve complex dose distribution for therapy involving extended volumes such as total marrow and total lymph node treatment. Dynamic electron arc radiotherapy (DEAR) not only overcomes the deficiencies of conventional electron therapy in dose conformity and homogeneity but also achieves so without patient-specific shields. The combination of MLC and couch tracking provides improved motion management of thoracic and abdominal tumors. A substantial body of work has been done in these technological advances for clinical translation. The proposed symposium will provide a timely review of these exciting opportunities. Learning Objectives: Recognize the potential of using digitally controlled linacs for clinically significant improvements in delivered dose distributions for various treatment sites. Identify existing approaches to treatment planning, optimization and delivery for treatment techniques utilizing the advanced functions of digital linacs and venues for further development and improvement. Understand methods for testing and validating delivery system performance. Identify tools available on current delivery systems for implementation and control for such treatments. Obtain the update in clinical applications, trials and regulatory approval. K. Sheng, NIH U19AI067769, NIH R43CA183390, NIH R01CA188300, Varian Medical Systems V. Yu, Varian Medical Systems, AAPM Summer Undergraduate Fellowship, NSF graduate fellowship S. Nill, Elekta AB. Cancer Research UK under Programme C33589/A19727, NIHR Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2016

TH-AB-BRB-03: 4n Radiotherapy

Current state-of-the art digital C-arm medical linear accelerators are capable of delivering radiation treatments with high level of automation, which affords coordinated motions of gantry, couch, and multileaf collimator (MLC) with dose rate modulations. The new machine capacity has shown the potential to bring substantially improved radiation dosimetry and/or delivery efficiency to many challenging diseases. Combining an integrated beam orientation optimization algorithm with automated machine navigation, markedly improved dose conformity has been achieved using 4ρ therapy. Trajectory modulated radiation therapy (TMAT) can be used to deliver highly conformal dose to partial breast or to carve complex dose distribution for therapy involving extended volumes such as total marrow and total lymph node treatment. Dynamic electron arc radiotherapy (DEAR) not only overcomes the deficiencies of conventional electron therapy in dose conformity and homogeneity but also achieves so without patient-specific shields. The combination of MLC and couch tracking provides improved motion management of thoracic and abdominal tumors. A substantial body of work has been done in these technological advances for clinical translation. The proposed symposium will provide a timely review of these exciting opportunities. Learning Objectives: Recognize the potential of using digitally controlled linacs for clinically significant improvements in delivered dose distributions for various treatment sites. Identify existing approaches to treatment planning, optimization and delivery for treatment techniques utilizing the advanced functions of digital linacs and venues for further development and improvement. Understand methods for testing and validating delivery system performance. Identify tools available on current delivery systems for implementation and control for such treatments. Obtain the update in clinical applications, trials and regulatory approval. K. Sheng, NIH U19AI067769, NIH R43CA183390, NIH R01CA188300, Varian Medical Systems V. Yu, Varian Medical Systems, AAPM Summer Undergraduate Fellowship, NSF graduate fellowship S. Nill, Elekta AB. Cancer Research UK under Programme C33589/A19727, NIHR Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2016

TH-AB-BRB-05: Using a Research Real-Time Control Interface to Go Beyond Dynamic MLC Tracking

Current state-of-the art digital C-arm medical linear accelerators are capable of delivering radiation treatments with high level of automation, which affords coordinated motions of gantry, couch, and multileaf collimator (MLC) with dose rate modulations. The new machine capacity has shown the potential to bring substantially improved radiation dosimetry and/or delivery efficiency to many challenging diseases. Combining an integrated beam orientation optimization algorithm with automated machine navigation, markedly improved dose conformity has been achieved using 4ρ therapy. Trajectory modulated radiation therapy (TMAT) can be used to deliver highly conformal dose to partial breast or to carve complex dose distribution for therapy involving extended volumes such as total marrow and total lymph node treatment. Dynamic electron arc radiotherapy (DEAR) not only overcomes the deficiencies of conventional electron therapy in dose conformity and homogeneity but also achieves so without patient-specific shields. The combination of MLC and couch tracking provides improved motion management of thoracic and abdominal tumors. A substantial body of work has been done in these technological advances for clinical translation. The proposed symposium will provide a timely review of these exciting opportunities. Learning Objectives: Recognize the potential of using digitally controlled linacs for clinically significant improvements in delivered dose distributions for various treatment sites. Identify existing approaches to treatment planning, optimization and delivery for treatment techniques utilizing the advanced functions of digital linacs and venues for further development and improvement. Understand methods for testing and validating delivery system performance. Identify tools available on current delivery systems for implementation and control for such treatments. Obtain the update in clinical applications, trials and regulatory approval. K. Sheng, NIH U19AI067769, NIH R43CA183390, NIH R01CA188300, Varian Medical Systems V. Yu, Varian Medical Systems, AAPM Summer Undergraduate Fellowship, NSF graduate fellowship S. Nill, Elekta AB. Cancer Research UK under Programme C33589/A19727, NIHR Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2016

TH-AB-BRB-04: Quality Assurance for Advanced Digital Linac Implementations

Current state-of-the art digital C-arm medical linear accelerators are capable of delivering radiation treatments with high level of automation, which affords coordinated motions of gantry, couch, and multileaf collimator (MLC) with dose rate modulations. The new machine capacity has shown the potential to bring substantially improved radiation dosimetry and/or delivery efficiency to many challenging diseases. Combining an integrated beam orientation optimization algorithm with automated machine navigation, markedly improved dose conformity has been achieved using 4ρ therapy. Trajectory modulated radiation therapy (TMAT) can be used to deliver highly conformal dose to partial breast or to carve complex dose distribution for therapy involving extended volumes such as total marrow and total lymph node treatment. Dynamic electron arc radiotherapy (DEAR) not only overcomes the deficiencies of conventional electron therapy in dose conformity and homogeneity but also achieves so without patient-specific shields. The combination of MLC and couch tracking provides improved motion management of thoracic and abdominal tumors. A substantial body of work has been done in these technological advances for clinical translation. The proposed symposium will provide a timely review of these exciting opportunities. Learning Objectives: Recognize the potential of using digitally controlled linacs for clinically significant improvements in delivered dose distributions for various treatment sites. Identify existing approaches to treatment planning, optimization and delivery for treatment techniques utilizing the advanced functions of digital linacs and venues for further development and improvement. Understand methods for testing and validating delivery system performance. Identify tools available on current delivery systems for implementation and control for such treatments. Obtain the update in clinical applications, trials and regulatory approval. K. Sheng, NIH U19AI067769, NIH R43CA183390, NIH R01CA188300, Varian Medical Systems V. Yu, Varian Medical Systems, AAPM Summer Undergraduate Fellowship, NSF graduate fellowship S. Nill, Elekta AB. Cancer Research UK under Programme C33589/A19727, NIHR Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2011

Validation of a new control system for Elekta accelerators facilitating continuously variable dose rate

Purpose: Elekta accelerators controlled by the current clinically used accelerator control system, Desktop 7.01 (D7), uses binned variable dose rate (BVDR) for volumetric modulated arc therapy (VMAT). The next version of the treatment control system (Integrity) supports continuously variable dose rate (CVDR) as well as BVDR. Using CVDR opposed to BVDR for VMAT has the potential of reducing the treatment time but may lead to lower dosimetric accuracy due to faster moving accelerator parts. Using D7 and a test version of Integrity, differences in ability to control the accelerator, treatment efficiency, and dosimetric accuracy between the two systems were investigated. Methods: Single parameter tests were designed to expose differences in the way the two systems control the movements of the accelerator. In these tests, either the jaws, multi leaf collimators (MLCs), or gantry moved at constant speed while the dose rate was changed in discrete steps. The positional errors of the moving component and dose rate were recorded using the control systems with a sampling frequency of 4 Hz. The clinical applicability of Integrity was tested using 15 clinically used VMAT plans (5 prostate, 5 H and N, and 5 lung) generated by the SmartArc algorithm in PINNACLE. The treatment time was measured from beam-on to beam-off and the accuracy of the dose delivery was assessed by comparing DELTA4 measurements and PINNACLE calculated doses using gamma evaluation. Results: The single parameter tests showed that Integrity had an improved feedback between gantry motion and dose rate at the slight expense of MLC control compared to D7. The single parameter test did not reveal any significant differences in the control of either jaws or backup jaws between the two systems. These differences in gantry and MLC control together with the use of CVDR gives a smoother Integrity VMAT delivery compared to D7 with less abrupt changes in accelerator motion. Gamma evaluation (2% of 2 Gy and 2 mm) of the calculated doses and DELTA4 measured doses corrected for systematic errors showed an average pass rate of more than 97.8% for both D7, Integrity BVDR, and Integrity CVDR deliveries. Direct comparisons between the measured doses using strict gamma criteria of 0.5% and 0.5 mm showed excellent agreement between D7 and Integrity delivered doses with average pass rates above 95.7%. Finally, the Integrity control system resulted in a significant 35% (55 {+-} 13 s) reduction in treatment time, on average. Conclusions: Single parameter tests showed that the two control systems differed in their feedback loops between MLC, gantry, and dose rate. These differences made the VMAT deliveries more smooth using the new Integrity treatment control system, compared to the current Desktop 7.01. Together with the use of CVDR, which results in less abrupt changes in dose rate, this further increases the smoothness of the delivery. The use of CVDR for VMAT with the Integrity desktop results in a significant reduction in treatment time compared to BVDR with an average reduction of 35%. This decrease in delivery time was achieved without compromising the dosimetric accuracy.

07 ISOTOPE AND RADIATION SOURCES↗

DOE OSTI2018

An inorganic coating and flexible regulating in situ of stent endothelialization by the controllable ion releasing

Highlights: • The Cu/Ti film with regulating the various responses of ECs and SMCs has been prepared. • The hemocompatibility could be adjusted via the ratio of Cu/Ti. • The volume and velocity of copper ion released from film was designed via the preparation processing. - Abstract: A facile approach to fabricate an inorganic coating with favorable blood compatibility and accelerating endothelialization is reported. The inorganic coating with various ratios of Cu and Ti atom are prepared on 316 L stainless steel by physical vapor deposition method. The phase composition and structure as well as the element concentration of the coating are investigated by X-ray diffraction and X-photoelectron energy spectrum. The hemolysis ratio, clotting time and platelet adhesion are utilized to characterize the materials’ hemocompatibility, the copper ion releasing was also investigated via immersing test. The result indicates that copper-titanium coating show good compatibility; however, as the ratio of Cu to Ti increases, the hemolysis ratio also increases. The endothelialization degree was accelerated owing to maintain less than 7.0 μg/ml of Cu{sup 2+} concentrate, and endothelial cells proliferate more readily than smooth muscle cells. The results demonstrate that this degradable copper-containing coating is suitable as a new surface modification for vascular stents.

36 MATERIALS SCIENCE↗

DOE OSTI2014

SU-E-T-21: A Novel Sampling Algorithm to Reduce Intensity-Modulated Radiation Therapy (IMRT) Optimization Time

Purpose: The IMRT optimization problem requires substantial computer time to find optimal dose distributions because of the large number of variables and constraints. Voxel sampling reduces the number of constraints and accelerates the optimization process, but usually deteriorates the quality of the dose distributions to the organs. We propose a novel sampling algorithm that accelerates the IMRT optimization process without significantly deteriorating the quality of the dose distribution. Methods: We included all boundary voxels, as well as a sampled fraction of interior voxels of organs in the optimization. We selected a fraction of interior voxels using a clustering algorithm, that creates clusters of voxels that have similar influence matrix signatures. A few voxels are selected from each cluster based on the pre-set sampling rate. Results: We ran sampling and no-sampling IMRT plans for de-identified head and neck treatment plans. Testing with the different sampling rates, we found that including 10% of inner voxels produced the good dose distributions. For this optimal sampling rate, the algorithm accelerated IMRT optimization by a factor of 2–3 times with a negligible loss of accuracy that was, on average, 0.3% for common dosimetric planning criteria. Conclusion: We demonstrated that a sampling could be developed that reduces optimization time by more than a factor of 2, without significantly degrading the dose quality.

60 APPLIED LIFE SCIENCES↗